RecruitingNCT07119411

ICU Background Early Awareness for Critical deterioratiON

ICU Background Early Awareness for Critical deterioratiON (BEACON)


Sponsor

ETH Zurich

Enrollment

1,962 participants

Start Date

Dec 1, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

The study will compare ICU sub-units, those with additional support of a clinician awareness system, ICU Beacon, and those receiving the standard of care. The win-ratio composite outcome will be assessed by comparing patients by study group and stratified by APACHE score at admission.


Eligibility

Min Age: 18 Years

Inclusion Criteria1

  • admission to intensive care unit

Exclusion Criteria3

  • age < 18 years
  • presence of documented refused general consent form (at database closure)
  • admission for the sole purpose of dying/organ donation or evaluation of such

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERICU Beacon

Availability of a proprietary clinician awareness for potential organ deterioration software to treating clinicians (ICU Beacon) in addition to the standard of care.


Locations(1)

Inselspital - Universitätsspital Bern

Bern, Switzerland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07119411


Related Trials